OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Current state of the epilepsy drug and device pipeline
Samuel W. Terman, Laura Kirkpatrick, Lisa F. Akiyama, et al.
Epilepsia (2024) Vol. 65, Iss. 4, pp. 833-845
Open Access | Times Cited: 14
Samuel W. Terman, Laura Kirkpatrick, Lisa F. Akiyama, et al.
Epilepsia (2024) Vol. 65, Iss. 4, pp. 833-845
Open Access | Times Cited: 14
Showing 14 citing articles:
Channelopathies in epilepsy: an overview of clinical presentations, pathogenic mechanisms, and therapeutic insights
Andy Cheuk‐Him Ng, Mohamed Chahine, Morris H. Scantlebury, et al.
Journal of Neurology (2024) Vol. 271, Iss. 6, pp. 3063-3094
Closed Access | Times Cited: 8
Andy Cheuk‐Him Ng, Mohamed Chahine, Morris H. Scantlebury, et al.
Journal of Neurology (2024) Vol. 271, Iss. 6, pp. 3063-3094
Closed Access | Times Cited: 8
Progress report on new medications for seizures and epilepsy: A summary of the 17th Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVII). I. Drugs in preclinical and early clinical development
Meir Bialer, Svein I. Johannessen, Matthias J. Koepp, et al.
Epilepsia (2024) Vol. 65, Iss. 10, pp. 2831-2857
Closed Access | Times Cited: 8
Meir Bialer, Svein I. Johannessen, Matthias J. Koepp, et al.
Epilepsia (2024) Vol. 65, Iss. 10, pp. 2831-2857
Closed Access | Times Cited: 8
Progress report on new medications for seizures and epilepsy: A summary of the 17th Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVII). II. Drugs in more advanced clinical development
Meir Bialer, Svein I. Johannessen, Matthias J. Koepp, et al.
Epilepsia (2024) Vol. 65, Iss. 10, pp. 2858-2882
Open Access | Times Cited: 8
Meir Bialer, Svein I. Johannessen, Matthias J. Koepp, et al.
Epilepsia (2024) Vol. 65, Iss. 10, pp. 2858-2882
Open Access | Times Cited: 8
Withaferin A protects against epilepsy by promoting LCN2-mediated astrocyte polarization to stopping neuronal ferroptosis
Zixian Zhou, Pengcheng Zhang, Dongshan Ya, et al.
Phytomedicine (2024) Vol. 132, pp. 155892-155892
Closed Access | Times Cited: 4
Zixian Zhou, Pengcheng Zhang, Dongshan Ya, et al.
Phytomedicine (2024) Vol. 132, pp. 155892-155892
Closed Access | Times Cited: 4
Therapeutic Advances in Drug-Resistant Epilepsy
Edwin Humberto Hodelin-Maynard, Diana Țînț, Judith González González, et al.
American Journal of Therapeutics (2025)
Closed Access
Edwin Humberto Hodelin-Maynard, Diana Țînț, Judith González González, et al.
American Journal of Therapeutics (2025)
Closed Access
Targeting Kv7 Potassium Channels for Epilepsy
Emilio Perucca, Maurizio Taglialatela
CNS Drugs (2025)
Open Access
Emilio Perucca, Maurizio Taglialatela
CNS Drugs (2025)
Open Access
Stimuli-responsive nanoscale drug delivery system for epilepsy theranostics
Qi Zhang, Yi Wang, Di Wu, et al.
Acta Biomaterialia (2025)
Closed Access
Qi Zhang, Yi Wang, Di Wu, et al.
Acta Biomaterialia (2025)
Closed Access
Design and synthesis of novel cyclohexanecarboxamides with anticonvulsant effect by activating Nrf2-ARE pathway
Walaa Hamada Abd‐Allah, Mohammed S. Abdel‐Maksoud, Marawan A. Elbaset, et al.
Bioorganic Chemistry (2025) Vol. 159, pp. 108357-108357
Closed Access
Walaa Hamada Abd‐Allah, Mohammed S. Abdel‐Maksoud, Marawan A. Elbaset, et al.
Bioorganic Chemistry (2025) Vol. 159, pp. 108357-108357
Closed Access
Clinical trials of prevention of acquired epilepsy: New proof‐of‐concept approach to restart trials
Pavel Klein, Matthias J. Koepp, Alexander Rotenberg, et al.
Epilepsia (2025)
Closed Access
Pavel Klein, Matthias J. Koepp, Alexander Rotenberg, et al.
Epilepsia (2025)
Closed Access
Identification of a new retigabine derivative with improved photostability for selective activation of neuronal Kv7 channels and antiseizure activity
Hongbin Wang, 真 高橋, Kun Luan, et al.
Epilepsia (2024) Vol. 65, Iss. 10, pp. 2923-2934
Open Access | Times Cited: 3
Hongbin Wang, 真 高橋, Kun Luan, et al.
Epilepsia (2024) Vol. 65, Iss. 10, pp. 2923-2934
Open Access | Times Cited: 3
Anxiety and Epilepsy: Current Understanding and Future Perspectives
N.V.L. Suvarchala Reddy, M. Ganga Raju, D. Pushyami Sudha, et al.
International Journal of Innovative Science and Research Technology (IJISRT) (2024), pp. 344-349
Open Access | Times Cited: 1
N.V.L. Suvarchala Reddy, M. Ganga Raju, D. Pushyami Sudha, et al.
International Journal of Innovative Science and Research Technology (IJISRT) (2024), pp. 344-349
Open Access | Times Cited: 1
Global, Regional, and National Burdens of Developmental Disabilities in Children and Adolescents from 1990 to 2021: A Trend Analysis Insights from GBD 2021 Data
Xie YiJun, Yao Li, Hui Liu, et al.
(2024)
Closed Access
Xie YiJun, Yao Li, Hui Liu, et al.
(2024)
Closed Access
Using oral topiramate for primary generalized and focal-to-bilateral tonic-clonic seizures in patients 2 years of age and older: a review of the literature
Slobodan Јаnkovic, Dobrivoje Stojadinović, Vera Dabanović
Expert Review of Neurotherapeutics (2024), pp. 1-9
Closed Access
Slobodan Јаnkovic, Dobrivoje Stojadinović, Vera Dabanović
Expert Review of Neurotherapeutics (2024), pp. 1-9
Closed Access
BRIVA‐ONE study: 12‐month outcomes of brivaracetam monotherapy in clinical practice
Vicente Villanueva, E. Villar, A Fernández-Cabrera, et al.
Epilepsia Open (2024)
Open Access
Vicente Villanueva, E. Villar, A Fernández-Cabrera, et al.
Epilepsia Open (2024)
Open Access
